0

Azilsartan

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP147403030
CAS147403-03-0
Structure
MDL NumberMFCD00916395
Molecular Weight456.45
InChI KeyKGSXMPPBFPAXLY-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 15 mg/mL (clear solution)
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size10MG, 50MG
Storage Conditions2-8°C
1

A Randomized Trial of the Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone

Michael A Weber, Peter Sever, Attila Juhasz, Andrew Roberts, Charlie Cao

J Renin Angiotensin Aldosterone Syst. Jul-Sep 2018;19(3):1470320318795000.

PMID: 30175930

1

Angiotensin II Receptor Antagonists

PMID: 31643954

1

Azilsartan Causes Natriuresis Due to Its Sympatholytic Action in Kidney Disease

Satoshi Kidoguchi, Naoki Sugano, Koki Takane, Yasuhito Takahashi, Norihiko Morisawa, Miki Yarita, Naomi Hayashi-Ishikawa, Goro Tokudome, Takashi Yokoo

Hypertens Res. 2019 Oct;42(10):1507-1517.

PMID: 31138899

1

Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension

Yuhei Shiga, Shin-Ichiro Miura, Kota Motozato, Kenji Norimatsu, Masaya Yano, Yuka Hitaka, Sen Adachi, Takashi Kuwano, Ken Inoue, Asao Inoue, Kazuaki Fujisawa, Tetsuro Shirotani, Takaaki Kusumoto, Munehito Ideishi, etc.

Int Heart J. 2017 May 31;58(3):416-421.

PMID: 28496022

1

Effects of Azilsartan Compared With Telmisartan on Insulin Resistance in Patients With Essential Hypertension and Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial

Mitsuhide Naruse, Yasuhiro Koike, Nozomu Kamei, Ryuichi Sakamoto, Yuko Yambe, Michinori Arimitsu

PLoS One. 2019 Apr 3;14(4):e0214727.

PMID: 30943275

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode